Taiwanese company United Biomedical Inc. (UBI) Asia on Wednesday applied for emergency use authorization (EUA) in Taiwan for its COVID-19 vaccine candidate, after releasing the interim results of its Phase 2 clinical trials last weekend, according to its subsidiary.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
12/01/2024 12:28 PM - Politics
President Lai arrives in Hawaii before visiting South Pacific allies
12/01/2024 10:19 AM - Society
Mother dead, son rescued from Taipei public housing blaze
12/01/2024 10:07 AM - Sports
World Boxing president apologizes for unclear gender policies
12/01/2024 12:29 AM - Culture
CNA president, Taiwan TV host win Asian Television Awards
11/30/2024 11:59 PM